SCHEMBL2499307

SCHEMBL2499307

Cc1cc(C)c(C(=O)C(CP=O)C(=O)c2c(C)cc(C)cc2C)c(C)c1

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.36
LMNA P02545 3/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
HPGD P15428 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
MCOLN3 Q8TDD5 1/20 0.36
ALDH1A1 P00352 3/20 0.36
GAA P10253 2/20 0.36
MAPT P10636 2/20 0.34
MAPK1 P28482 1/20 0.34
TAS1R3 Q7RTX0 3/20 0.33
TAS1R1 Q7RTX1 3/20 0.33
TAS1R2 Q8TE23 3/20 0.33
CRHR1 P34998 1/20 0.32
POLB P06746 2/20 0.32
RAB9A P51151 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5997921 0.92 KMT2A (0.35) KDM4ELMNAMEN1KMT2AHPGD
SCHEMBL5996433 0.91 KDM4E (0.37) KDM4ELMNAMEN1KMT2AHPGD
SCHEMBL5994805 0.88 ALDH1A1 (0.35) KMT2AL3MBTL1SMN1; SMN2ALDH1A1GAA
SCHEMBL5996310 0.87 KMT2A (0.41) LMNAMEN1KMT2AHPGDALDH1A1
SCHEMBL5996153 0.87 KMT2A (0.35) KDM4ELMNAMEN1KMT2AHPGD
SCHEMBL6403712 0.84 HTR1D (0.34) KDM4EHPGDL3MBTL1ALDH1A1MAPT
SCHEMBL5994591 0.84 CYP3A4 (0.39) KDM4ELMNAMEN1KMT2AHPGD
SCHEMBL152304 0.81 L3MBTL1 (0.36) LMNAMEN1KMT2AHPGDL3MBTL1
SCHEMBL6454376 0.81 HPGD (0.36) KDM4ELMNAMEN1KMT2AHPGD
SCHEMBL4371155 0.80 HPGD (0.33) KDM4ELMNAMEN1KMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1852134-B1 ORTHOPEDIC PHOTO-CURABLE FIXING MATERIAL ALCARE CO LTD (JP) 2015-04-01 EP disclosed
EP-2105452-B1 AQUEOUS URETHANE RESIN COMPOSITION MITSUI CHEMICALS INC (JP) 2013-03-20 EP disclosed
US-8030227-B2 Photocurable fixture for orthopedic surgery ALCARE CO., LTD. (JP) 2011-10-04 US disclosed
US-20090264551-A1 Photocurable fixture for orthopedic surgery background of the invention ALCARE CO., LTD. 2009-10-22 US disclosed
EP-2105452-A1 AQUEOUS URETHANE RESIN COMPOSITION Mitsui Chemicals, Inc. (JP) 2009-09-30 EP disclosed
US-20080045622-A1 Photocurable Fixture for Orthopedic Surgery ALCARE CO., LTD. (JP) 2008-02-21 US disclosed
EP-1852134-A1 ORTHOPEDIC PHOTO-CURABLE FIXING MATERIAL Alcare Co., Ltd. (JP) 2007-11-07 EP disclosed
US-7214830-B2 Process for the preparation of acylphosphines, acyl oxides and acyl sulfides CIBA SPECIALTY CHEMICALS CORPORATION (US) 2007-05-08 US disclosed
US-7094931-B2 Process for the preparation of acylphosphines, acyl oxides and acyl sulfides CIBA SPECIALTY CHEMICALS CORPORATION (US) 2006-08-22 US disclosed
EP-1135399-B2 PROCESS FOR PREPARING ACYLPHOSPHINES AND DERIVATIVES CIBA SC HOLDING AG (CH) 2006-08-09 EP disclosed
US-20040248855-A1 Process for the preparation of acylphosphines, acyl oxides and acyl sulfides IGM GROUP B.V. (NL) 2004-12-09 US disclosed
EP-0874012-B1 Coating composition for optical fiber MITSUI TAKEDA CHEMICALS INC (JP) 2004-03-10 EP disclosed
EP-1135399-B1 PROCESS FOR PREPARING ACYLPHOSPHINES AND DERIVATIVES CIBA SC HOLDING AG (CH) 2002-08-07 EP disclosed
EP-1135399-A1 PROCESS FOR PREPARING ACYLPHOSPHINES AND DERIVATIVES Ciba SC Holding AG (CH) 2001-09-26 EP disclosed
US-6075065-A COMPRISES A POLYURETHANE (METH)ACRYLATE OLIGOMER, AN ETHYLENICALLY UNSATURATED COMPOUND, A BISACYLPHOSPHINE OXIDE-SERIES PHOTOPOLYMERIZATION INITIATOR, AND A TERTIARY AMINE AND NO TIN COMPONENT TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2000-06-13 US disclosed
WO-2000032612-A1 PROCESS FOR PREPARING ACYLPHOSPHINES AND DERIVATIVES CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2000-06-08 WO disclosed
US-6057034-A COMPRISING A POLYURETHANE (METH)ACRYLATE OLIGOMER MADE FORM A POLYISOCYANATE, POLYOL, AND HYDROXY-CONTAINING ACRYLATE; AN ETHYLENICALLY UNSATURATED MONOMER, AND PHOTOPOLYMERIZATION INITIATOR; LOW VISCOSITY FOR RAPID FIBER-DRAWING TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2000-05-02 US disclosed
EP-0874012-A1 Coating composition for optical fiber TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1998-10-28 EP disclosed
EP-0849296-A2 A photocurable resin composition and a method for producing the same TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1998-06-24 EP disclosed
US-5534559-A UNSATURATED POLYESTERS CIBA-GEIGY CORPORATION (US) 1996-07-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040248855-A1 Process for the preparation of acylphosphines, acyl oxides and acyl sulfides AGPS, PHOSPHO1, AGPAT2 KDM4E 3169/4885LMNA 2186/4885MEN1 1567/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.